DUALVIII: more patients met treatment targets with IDegLira (insulin degludec/liraglutide) vs IGlar U100 by week 26 in a 104 week randomised trial mirroring clinical practice

Sesti G., Bardtrum L., Daddelen S., Halladin N., Haluzik M., Orsy P., ...More

55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona, Spain, 16 - 20 September 2019, vol.62 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 62
  • City: Barcelona
  • Country: Spain
  • Hacettepe University Affiliated: Yes